MHC Woes


anonymous

Guest
Sound off here about Livalo coverage. I'll start. How does Vascepa keep getting wins and Livalo takes it on the chin over and over with the plans? Why is this tolerated? Does the MHC team have ANY relationships at ALL with key people at the big plans? Who is the MHC team accountable to? What happens next year when Crestor goes generic? It's all very frustrating.
 












If managed care isn't bad enough, we are now losing UHC and Crestor will be generic next year. Where is our MC people??? Why does Vascepa have excellent coverage and a great list of plans on their tablets to show their customers?